Copy number signatures and mutational processes in ovarian carcinoma

被引：271

作者：

Macintyre, Geoff ^{[1
]}

Goranova, Teodora E. ^{[1
]}

De Silva, Dilrini ^{[1
]}

Ennis, Darren ^{[2
]}

Piskorz, Anna M. ^{[1
]}

Eldridge, Matthew ^{[1
]}

Sie, Daoud ^{[3
]}

Lewsley, Liz-Anne ^{[4
]}

Hanif, Aishah ^{[4
]}

Wilson, Cheryl ^{[4
]}

Dowson, Suzanne ^{[2
]}

Glasspool, Rosalind M. ^{[5
]}

Lockley, Michelle ^{[6
,7
]}

Brockbank, Elly ^{[8
]}

Montes, Ana ^{[9
]}

Walther, Axel ^{[10
]}

Sundar, Sudha ^{[11
]}

Edmondson, Richard ^{[12
,13
]}

Hall, Geoff D. ^{[14
]}

Clamp, Andrew ^{[15
]}

Gourley, Charlie ^{[16
]}

Hall, Marcia ^{[17
]}

Fotopoulou, Christina ^{[18
]}

Gabra, Hani ^{[18
,19
]}

Paul, James ^{[4
]}

Supernat, Anna ^{[1
]}

Millan, David ^{[20
]}

Hoyle, Aoisha ^{[20
]}

Bryson, Gareth ^{[20
]}

Nourse, Craig ^{[2
]}

Mincarelli, Laura ^{[2
]}

Sanchez, Luis Navarro ^{[2
]}

Ylstra, Bauke ^{[3
]}

Jimenez-Linan, Mercedes ^{[21
]}

Moore, Luiza ^{[21
]}

Hofmann, Oliver ^{[2
,22
]}

Markowetz, Florian ^{[1
]}

McNeish, Iain A. ^{[2
,5
,18
]}

Brenton, James D. ^{[1
,21
,23
]}

机构：

[1] Canc Res UK Cambridge Inst, Cambridge, England

[2] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland

[3] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands

[4] Univ Glasgow, Inst Canc Sci, Cancer Res UK Clin Trials Unit, Glasgow, Lanark, Scotland

[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland

[6] Queen Mary Univ London, Barts Canc Inst, London, England

[7] Univ Coll London Hosp, London, England

[8] Barts Hlth NHS Trust, London, England

[9] Guys Hosp, London, England

[10] Bristol Canc Inst, Bristol, Avon, England

[11] City Hosp, Birmingham, W Midlands, England

[12] Univ Manchester, St Marys Hosp, Fac Biol Med & Hlth, Div Canc Sci, Manchester, Lancs, England

[13] Manchester Acad Hlth Sci Ctr, Cent Manchester NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr,Dept Obstet & Gynaec, Manchester, Lancs, England

[14] St Jamess Inst Oncol, Leeds, W Yorkshire, England

[15] Christie Hosp, Manchester, Lancs, England

[16] Univ Edinburgh, MRC IGMM, Nicola Murray Ctr Ovarian Canc Res, Edinburgh, Midlothian, Scotland

[17] Mt Vernon Canc Ctr, Northwood, Middx, England

[18] Imperial Coll, Dept Surg & Canc, Div Canc & Ovarian Canc Action Res Ctr, London, England

[19] AstraZeneca, Early Clin Dev, IMED Biotech Unit, Cambridge, England

[20] Queen Elizabeth Univ Hosp, Dept Pathol, Glasgow, Lanark, Scotland

[21] Addenbrookes Hosp, Cambridge, England

[22] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia

[23] Univ Cambridge, Dept Oncol, Cambridge, England

来源：

NATURE GENETICS | 2018年 / 50卷 / 09期

关键词：

TANDEM DUPLICATOR PHENOTYPE; GRADE SEROUS CARCINOMA; BREAST-CANCER; OPEN-LABEL; R PACKAGE; DNA; REVEALS; QUANTIFICATION; IDENTIFICATION; AMPLIFICATION;

D O I：

10.1038/s41588-018-0179-8

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The genomic complexity of profound copy number aberrations has prevented effective molecular stratification of ovarian cancers. Here, to decode this complexity, we derived copy number signatures from shallow whole-genome sequencing of 117 high-grade serous ovarian cancer (HGSOC) cases, which were validated on 527 independent cases. We show that HGSOC comprises a continuum of genomes shaped by multiple mutational processes that result in known patterns of genomic aberration. Copy number signature exposures at diagnosis predict both overall survival and the probability of platinum-resistant relapse. Measurement of signature exposures provides a rational framework to choose combination treatments that target multiple mutational processes.

引用

页码：1262 / +

页数：12

共 50 条

[21] Signatures of mutational processes in human cancer
Alexandrov, Ludmil B.
MOLECULAR CANCER RESEARCH, 2017, 15
[22] Mutational signatures and processes in hepatobiliary cancers
Zhuravleva, Ekaterina
O'Rourke, Colm J.
Andersen, Jesper B.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (06) : 367 - 382
[23] Signatures of mutational processes in human cancer
Ludmil B. Alexandrov
Serena Nik-Zainal
David C. Wedge
Samuel A. J. R. Aparicio
Sam Behjati
Andrew V. Biankin
Graham R. Bignell
Niccolò Bolli
Ake Borg
Anne-Lise Børresen-Dale
Sandrine Boyault
Birgit Burkhardt
Adam P. Butler
Carlos Caldas
Helen R. Davies
Christine Desmedt
Roland Eils
Jórunn Erla Eyfjörd
John A. Foekens
Mel Greaves
Fumie Hosoda
Barbara Hutter
Tomislav Ilicic
Sandrine Imbeaud
Marcin Imielinski
Natalie Jäger
David T. W. Jones
David Jones
Stian Knappskog
Marcel Kool
Sunil R. Lakhani
Carlos López-Otín
Sancha Martin
Nikhil C. Munshi
Hiromi Nakamura
Paul A. Northcott
Marina Pajic
Elli Papaemmanuil
Angelo Paradiso
John V. Pearson
Xose S. Puente
Keiran Raine
Manasa Ramakrishna
Andrea L. Richardson
Julia Richter
Philip Rosenstiel
Matthias Schlesner
Ton N. Schumacher
Paul N. Span
Jon W. Teague
Nature, 2013, 500 : 415 - 421
[24] Tumor mutational burden, mutational signatures and copy number variation in lung cancer driven by the Ras-Raf-MEK-ERK pathway
Nicola, Pantelis A.
Burghel, George
Wallace, Andrew
Schlecht, Helene
Baker, Eleanor
Baker, Katie
Priest, Lynsey
Carter, Mathew
Moghadam, Sharzad
Rogan, Jane
Bristow, Robert G.
Newman, William
Blackhall, Fiona
Lindsay, Colin R.
CANCER RESEARCH, 2019, 79 (13)
[25] Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma
Essers, Paul B. M.
van der Heijden, Martijn
Vossen, David
de Roest, Reinout H.
Leemans, C. Rene
Brakenhoff, Ruud H.
van den Brekel, Michiel W. M.
Bartelink, Harry
Verheij, Marcel
Vens, Conchita
INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (06) : 1732 - 1739
[26] The copy number landscape of early stage ovarian high grade serous carcinoma
Cheng, Zhao
Mirza, Hasan B.
Ennis, Darren P.
Smith, Philip
Gavarro, Lena Morrill
Sokota, Chishimba
Giannone, Gaia
Goranova, Teodora
Bradley, Thomas
Piskorz, Anna
Lockley, Michelle
Kaur, Baljeet
Singh, Naveena
Tookman, Laura A.
Krell, Jonathan
McDermott, Jackie
Macintyre, Geoff
Markowetz, Florian
Brenton, James D.
McNeish, Iain A.
CANCER RESEARCH, 2022, 82 (12)
[27] Signatures of copy number alterations in human cancer
Steele, Christopher D.
Abbasi, Ammal
Islam, S. M. Ashiqul
Bowes, Amy L.
Khandekar, Azhar
Haase, Kerstin
Hames-Fathi, Shadi
Ajayi, Dolapo
Verfaillie, Annelien
Dhami, Pawan
McLatchie, Alex
Lechner, Matt
Light, Nicholas
Shlien, Adam
Malkin, David
Feber, Andrew
Proszek, Paula
Lesluyes, Tom
Mertens, Fredrik
Flanagan, Adrienne M.
Tarabichi, Maxime
Van Loo, Peter
Alexandrov, Ludmil B.
Pillay, Nischalan
NATURE, 2022, 606 (7916) : 984 - +
[28] Signatures of copy number alterations in human cancer
Christopher D. Steele
Ammal Abbasi
S. M. Ashiqul Islam
Amy L. Bowes
Azhar Khandekar
Kerstin Haase
Shadi Hames-Fathi
Dolapo Ajayi
Annelien Verfaillie
Pawan Dhami
Alex McLatchie
Matt Lechner
Nicholas Light
Adam Shlien
David Malkin
Andrew Feber
Paula Proszek
Tom Lesluyes
Fredrik Mertens
Adrienne M. Flanagan
Maxime Tarabichi
Peter Van Loo
Ludmil B. Alexandrov
Nischalan Pillay
Nature, 2022, 606 : 984 - 991
[29] Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures
Oliveira, Douglas V. N. P.
Schnack, Tine H.
Poulsen, Tim S.
Christiansen, Anne P.
Hogdall, Claus K.
Hogdall, Estrid V.
CANCERS, 2021, 13 (20)
[30] Genome-wide Copy Number Alteration Signatures Reliably Predict IDH Mutational Status in Diffuse Astrocytic Gliomas
Nuechterlein, Nicholas
Holland, Eric
Shapiro, Linda
Cimino, Patrick
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 564 - 564

← 1 2 3 4 5 →